A B S T R A C T Alveolar macrophages lavaged from human lungs contain protease activity at an optimum pH of 3.0 and possibly a lesser peak of activity at pH 5.5. Protease activity measured at pH 4.1 is inhibited by purified alpha-1-antitrypsin.
INTRODUCTION
Since Eriksson (1) observed that emphysema develops at an early age in people who are homozygotes for the genes that cause deficiency of alpha-1-antitrypsin, investigators have searched for enzymes that might cause emphysema in the absence of the enzyme inhibitor.
Most of the enzymes inhibited by alpha-1-antitrypsin, such as trypsin (2) , chymotrypsin (2) , pancreatic elastase (3), plasmin (4) , and thrombin (4) , are unlikely to be found in the lung parenchyma. The fibrinolytic enzyme in human neutrophils, which is inhibited by alpha-1-antitrypsin (5) , has access to pulmonary tissues in inflammatory states but the pathologic appearance of Received for publication 2 I The negative value for enzyme activity results from subtraction of the blank with TCA added before enzyme and hemoglobin.
to phagocytize heat-killed Candida albicans (9) , and less than 1% of them were neutrophils. In later experiments, III and IV (Table II) , enzymes were extracted from macrophages taken from lavages that were initially contaminated by blood cells, and the macrophages were separated from other cells by sedimentation at 1 g for 45 min and erythrocyte lysis using a 40 s pulse with distilled water. More than 96% of the cells in these preparations were alveolar macrophages. The cells were washed three times in sodium phosphate buffer, 0.1 M at pH 7.4, with 0.9% NaCl. They were then centrifuged at 250 g for 15 min and the supernate was discarded and the pellet frozen at -20'C until analyzed. Macrophages from the four patients used in experiments I and II (Table I) fluorescent antibody experiments except for those cells incubated longer before fluorescent staining in order to follow the time course of positive reactions. Suibjects. Macrophages from seven subjects were used for enzyme studies. The subjects were all over 55 yr of age and all were cigarette smokers except one who had stopped smoking 8 yr before surgery. These patients had bronchogenic carcinoma, but did not have endobronchial obstruction. Their forced vital capacities, lung volumes, and blood gases were within normal limits.
Cells from surgically removed lungs of eight patients and from lavaged lungs of three volunteers with no evidence of lung disease were used for fluorescent antibody studies. The patients ranged from 58 to 65 yr of age and seven were smokers and one had stopped smoking 11 yr before surgery. The three volunteers were nonsmokers and ranged from 25 to 37 yr of age. Their forced vital capacities, lung volumes, and blood gases were within normal limits. Two of the volunteers had the MM phenotype for alpha-1-antitrypsin. The third volunteer, a 37-yr old man, had the ZZ phenotype and a total trypsin-inhibiting capacity of 13.5 mg of trypsin/100 ml of serum. He was asymptomatic and had normal single breath carbon monoxide diffusion capacity, lung volumes, forced expired volume in 1 s expressed as a percent of the measured vital capacity, and airway resistance. Macrophages from all 11 subjects were treated with each of the regimens in Table  II . Two tubes were treated with each regimen when macrophages from surgical specimens were employed, and one tube was treated with each regimen when lungs of normal subjects were lavaged.
Emrzyne extraction. Macrophage pellets were thawed and 2 X 108 macrophages were suspended in 4.5 ml sodium acetate buffer, 0.01 M at pH 3.8. The suspension was homogenized at 00C in a homogenizer with a microhomogenizing attachment (Ivan Sorvall, Inc., Newtown, Conn.) and a dial setting of 6 for 60 s. The homogenate was centrifuged for 20 min at 37,400 g (Beckman model L-50 preparative ultracentrifuge, Beckman Instruments, Inc., Fullerton, Calif.). The supernate, which contained small and large granules with phase optics at X 1,250 magnification, was used for all enzyme studies.
Cathepsit assay. Cathepsin was measured by the method of Anson (11) . The cellular extract, 0.5 ml, was incubated with purified alpha-1-antitrypsin in 0.5 ml in the acetate buffer at 37°C for 60 min. The 0.5 ml contained 0.2, 0.1, 0.7, and 0.9 mg of alpha-l-antitrypsin in experiments I-IV, respectively. 1 ml of hemoglobin substrate, 2 g/100 ml in the acetate buffer, was added and the reagents were incubated again for 60 min at 37°C. An equal volume of 5% trichloroacetic acid (TCA) was added. The precipitated protein wvas removed by centrifugation and the remaining soluble peptides were measured by the method of Lowry, Rosebrough, Farr, and Randall (12) . The pH of the final material with all reactants added except the TCA was 4.0. The final optical densities were corrected for the effects of macrophage enzyme on other reactants and for the degree of TCA precipitability of the native proteins.
The pH titration of macrophage cathepsin was performed in a similar manner, but enzyme inhibition was not tested at other pH values. Analyses at pH 6 and above employed a Tris buffer, 0.1 M.
Fluorescent antibody studies. Fluorescent antibody studies were carried out using a Zeiss microscope (Carl Zeiss, Inc., New York) with a "-50" exciter filter, a halogen light source, and a barrier filter "53." Fluorescinated antirabbit gamma globulin (Roboz Surgical Instrument Co., Inc., Washington, D. C.) was absorbed with rat liver powder. Antihuman alpha-1-antitrypsin (Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif.) gave a single precipitin band against both purified alpha-1-antitrypsin and human serum in Ouchterlony analysis. N\either serum formed precipitin bands with FCS in Ouchterony analysis. The indirect staining technique of \Veller and Coons (13) was employed on macrophages fixed for 5 min in cold acetone. All slides were rated by the investigator without knowledge of the group to which the slide belonged. Treated macrophages from each subject were compared only to the simultaneously prepared controls from the same patient.
Alpha-1-antitrypsin was purified by the method of Rimon and Shamash (14) and Shamash and Rimon (15) , with some minor modifications. The alpha-1-antitrypsin was eluted from the ion-exchange column with starting buffer instead of a gradient and the last separation was performed with Pevikon block instead of starch block electrophoresis. Ouchterlony analysis showed that it gave a single line of precipitation against antiwhole human serum (Hyland Div., Travenol Laboratories, Inc.). In addition, one of the preparations yielded monospecific antisera when injected into each of two rabbits. The purified protein was used in all of the enzyme inhibition experiments. RESULTS
In four experiments, 81.7, 100, 89.0, and 100%c of the alveolar macrophage proteolytic enzyme or enzymes wvere inhibited by purified alpha-1-antitrypsin (Table I) Table I . The estimates of the number of moles of macrophage enzyme were based on the assumption that alpha-1-antitrypsin inhibits this enzyme in a stoichiometric manner as it does trypsin and chymotrypsin (2) . The denominators were measured directly. The pH profile of the enzyme (Fig. 1) indicates that maximal proteolytic activity for the hemoglobin substrate occurred at pH 3 and a shoulder on the pH curve at pH 4 suggests a second cathepsin. The tests with alpha-l-antitrypsin at pH 4.0 would be likely to measure enzymes from both peaks.
The treatment regimens and results of the fluorescent antibody studies are summarized in Table II . Alveolar macrophages from eight surgical specimens fluoresced when antisera to alpha-1-antitrypsin was followed by fluorescinated antirabbit gamma globulin (groups I and III). The fluorescence was distributed with a cytoplasmic pattern, excluding the nucleus (Fig. 2) . The cells that had human serum added before the antisera (group I) were no brighter than macrophages that had no human serum added (group III). Controls from groups II and IV did not fluoresce.
Alveolar macrophages lavaged from lungs of two normal volunteers with the MM phenotype for alpha-iantitrypsin showed an identical pattern to macrophages lavaged from surgical specimens; however, macrophages lavaged from one subject with ZZ phenotype for alphal-antitrypsin showed a faint diffuse positive fluorescence with indistinct periphery (Fig. 3A) when stained with regimen III (Table II) , and a distinctly lesser intensity than the same macrophages stained after incubation with normal serum (group I) (Fig. 3B) .
Macrophages treated with normal rabbit serum (group V) fluoresced with a peripheral ring of membrane-like fluorescence (Fig. 4A) or rarely with a homogeneous fluorescence (Fig. 4B) of the macrophage extract is between 3 and 4, but activity can still be measured up to pH 6.0. Although the pH of alveolar fluid in the adult is unknown, it has a mean value of 6.2 in fetal alveolar fluid and it has a low buffering capacity (16) . Therefore, if adult alveolar fluid is similar, this enzyme might have a low level of activity in adult alveoli. Since emphysema develops over many years and "emphysema models" produced by adding enzymes to tracheas occur in shorter time intervals (6) (7) (8) , it is likely that if proteolysis causes human emphysema then the level of proteolytic activity must be very small in relation to protein repair. Two additional factors favor inclusion of the macrophage cathepsin in the list of possible emphysema-producing enzymes: (a) our method examines proteolysis of hemoglobin over 60 min and may be too insensitive to detect a low level of proteolysis at higher pH, and (b) the pH in the area of the macrophage may be low during phagocytosis. There is evidence to indicate that human alveolar macrophages utilize anaerobic glycolysis (9) for part of their energy requirement during phagocytosis and acid by-products may result.
The significance of the alpha-1-antitrypsin found in human alveolar macrophages is not known but observations suggest that the inhibitor may have some physiologic role in the macrophage, perhaps related to the enzvnme in the macrophage that it inhibits. The cytoplasmicstaining pattern suggests that the inhibitor gained access to the interior of the macrophage, and the staining in macrophages lavaged from lungs of normal subjects inlicates that the fluorescence did not result from blood contamination at surgery. The reduced fluorescence of alpha-1-antitrypsin in alveolar macrophages from a subject with little alpha-1-antitrypsin in his blood was perhaps to be expected but serves to document the deficiency of the inhibitor in this perhaps critical anatomic area. In addition, when these day-old macrophages were incubated with normal serum they increased their fluorescent staining for alpha-1-antitrypsin. In contrast when macrophages were cultured in vitro for 72 h they lost their staining properties. Subsequently incubating these macrophages in normal serum did not restore their fluorescent staining for alpha-1-antitrypsin. Therefore, macrophages cultured in vitro for 3-5 days lose their ability to take up alpha-1-antitrypsin from their enviroment. Whereas data from one patient must be considered anecdotal, the rarity of deficient adult patients without lung disease makes it unlikely that we will be able to examine more patients in this category.
While the activity of alpha-1-antitrypsin in alveolar macrophages was not examined, Blondin, Rosenberg, and Janoff (17) have recently described an inhibitor of leukocyte protease, extracted from human alveolar macrophages. The inhibitor is acidic and has an isoelectric point of about 4.0. Alpha-1-antitrypsin shares these char-acteristics. The coexistence of the inhibitor and the cathepsin it inhibits in the same cell may be related to sequestration of the two agents in separate intracellular compartments or to the inability of alpha-1-antitrypsin to react with the cathepsin at a pH at which the cathepsin is inactive. It is also possible that the enzyme and inhibitor only interact when the cathepsin is released from the nmacrophage ( 18).
Finley et al. (10) and others (9) have shown that many more macrophages can be lavaged from lungs of cigarette smokers than from nonsmokers. Therefore, it is possible that emphysema could be caused by an increased level of macrophage enzyme in cigarette smokers or a decreased level of enzyme inhibitor in patients with a deficiency of alpha-1-antitrypsin. If further evidence supports this unifying hypothesis, the therapeutic use of the appropriate enzyme inhibitor might delay or prevent the emphysema that develops in both groups of patients.
